Mom Survives Lymphoma, but Bills Linger

Her oncologist had never seen a patient with lymphoma that looked as hopeless as the case of Susan Rabinowitz. It was difficult to treat because of a five-pound tumor that had grown so unwieldy that “it looked like someone put an implant in my left breast and forgot the right one,” she said. The tumor originated in her chest muscle, and she was told that if she had not gone to a doctor when she did, it would have broken through her skin.

As for why she had not sought medical care sooner, Ms. Rabinowitz was trying alternative medicine, and did not have health insurance. Her husband had been laid off from work and she was too young for Medicare. Now in remission, she and her husband, who is now working, are struggling to pay over $20,000 in debt from her treatment.

I don’t know how we got through it,” she said. “I’m sure there are people way, way worse off than us, but it’s such a shock to go from high income to nothing. You check your pride.”
Her situation is being highlighted by The Neediest Cases Fund, administered by The New York Times Company Foundation, which raises millions of dollars to help thousands of individuals and families in distress. The assistance is rendered by seven New York City social service agencies. The Times pays the Fund's expenses, so all contributions go directly to provide services and cash assistance to the poor. If you’d like to help, contact:

The New York Times Neediest Cases Fund
4 Chase Metrotech Center
7th Floor East; Lockbox 5193
Brooklyn, NY 11245
http://www.nytimes.com/neediest
(800) 381-0075

Blog Category: 

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap